| Filing date | Description | Form | View |
|---|---|---|---|
| D | View HTML | ||
| D | View HTML | ||
| D/A | View HTML | ||
| D | View HTML | ||
| D | View HTML | ||
| D | View HTML | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS | View HTML | |
UPLOAD |
UPLOAD | View HTML | |
Amendment to a previously filed DRS |
DRS/A | View HTML | |
Registration statement for face-amount certificate companies |
S-1 | View HTML |
Displaying 1 - 10 of 181 results
Data provided by Kaleidoscope.
Show all
2021
Q4 Earnings
Q3 Earnings
Q2 Earnings
Q1 Earnings
2020
Q4 Earnings
Q3 Earnings
Thursday, May 6, 2021 at 9:00 a.m. Pacific Time
The 2021 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) was held on Thursday, May 6, 2021.
Stockholders of record of Nurix common stock as of the close of business on March 12, 2021 were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2021 .
'